PRIVATE COMPANIES FOR PHASE-I STUDIES

被引:0
|
作者
LHOSTE, F
机构
[1] Service de Pharmacologie Clinique, Hôpital Necker-Enfants Malades, Paris, 75015, 161, rue de Sèvres
关键词
PHASE-I STUDY; SAFETY; HEALTHY VOLUNTEERS; PRIVATE CLINICAL LABORATORIES;
D O I
10.1111/j.1472-8206.1990.tb00084.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In France, the debate is still open regarding where phase I studies should take place. According to its strict definition, very few phase I studies are performed per year in our country. Because they are usually carried out on healthy volunteers, ethics and safety are intimately mixed in with such studies. Safety in these highly specific investigations is founded on 2 bases, first on the independence of the investigator and secondly on the laboratory environment. The economic independence and total lack of responsibility in this respect on the part of the investigator ensure that all ethical considerations including safety are focused on the personal interest of the volunteer who participates in the study.
引用
收藏
页码:S221 / S223
页数:3
相关论文
共 50 条
  • [21] REQUIREMENTS FOR PHARMACOKINETIC EVALUATION OF ANTIBIOTICS IN PHASE-I STUDIES
    BERGAN, T
    REVIEWS OF INFECTIOUS DISEASES, 1986, 8 : S319 - S324
  • [22] PHASE-I STUDIES OF RECOMBINANT INTERFERON-GAMMA
    LASZLO, J
    GOLDSTEIN, D
    GOCKERMAN, J
    HOOD, L
    HUANG, AT
    TRIOZZI, P
    SEDWICK, WD
    KOREN, H
    ELLINWOOD, EH
    TSO, CY
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (02): : 185 - 193
  • [23] SELECTION OF HEALTHY-VOLUNTEERS FOR PHASE-I STUDIES
    SIBILLE, M
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S167 - S176
  • [24] PHASE-I AND PHARMACOKINETIC STUDIES WITH THE PENTACYCLIC PYRROLOQUINONE MITOQUIDONE
    SPETH, PAJ
    GORE, ME
    PATEMAN, AJ
    NEWELL, DR
    BISHOP, JAM
    ELLIS, WJ
    GREEN, JA
    GUMBRELL, LA
    LINSSEN, PCM
    MILLER, A
    SMITH, IE
    MCVIE, JG
    DEMULDER, PHM
    DEPAUW, BE
    GRIGGS, JV
    BROWN, GW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (04) : 343 - 346
  • [25] HEART-RATE AS A PARAMETER OF PHASE-I STUDIES
    IMHOF, P
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1973, 23 (11A): : 1640 - 1643
  • [26] COORDINATED PHASE-I STUDIES FOR COOPERATIVE CHEMOTHERAPY GROUPS
    LOUIS, J
    CANCER CHEMOTHERAPY REPORTS, 1962, (16): : 99 - 105
  • [27] PRE-CLINICAL AND PHASE-I STUDIES OF MALONATOPLATINUM
    RIBAUD, P
    KELSEN, DP
    ALCOCK, N
    GARCIAGIRALT, E
    DUBOUCH, P
    YOUNG, CC
    MUGGIA, FM
    BURCHENAL, JH
    MATHE, G
    RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 156 - 162
  • [28] PRELIMINARY CLINICAL STUDIES (PHASE-I AND PHASE-II) WITH TALNIFLUMATE
    ROSITTO, V
    ARENOSO, HJ
    GONZALEZ, J
    PRENSA MEDICA ARGENTINA, 1980, 67 (15): : 753 - 756
  • [29] PHASE-I AND PHASE-II STUDIES WITH M-AMSA
    WEIL, M
    AUCLERC, MF
    AUCLERC, G
    JACQUILLAT, C
    SCHAISON, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 360 - 360
  • [30] VM26 - PHASE-I AND PHASE-II STUDIES
    MACBETH, FR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 87 - 91